Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.51 |
| ▸ | GSK3B | P49841 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.49 |
| ▸ | CLK2 | P49760 | 1/20 | 0.49 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | STAT3 | P40763 | 1/20 | 0.44 |
| ▸ | TOP2A | P11388 | 1/20 | 0.44 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30944930 | 1.00 | ADRB2 (0.56) | ADRB2KCNH2GSK3BKDM4EALDH1A1 | |
| SCHEMBL7008294 | 0.90 | ADRB2 (0.55) | ADRB2KCNH2GSK3BKDM4EALDH1A1 | |
| SCHEMBL1989474 | 0.90 | ADRB2 (0.61) | ADRB2KCNH2GSK3BKDM4EALDH1A1 | |
| SCHEMBL29391687 | 0.90 | ADRB2 (0.61) | ADRB2KCNH2GSK3BKDM4EALDH1A1 | |
| SCHEMBL7599453 | 0.90 | ADRB2 (0.65) | ADRB2KCNH2KDM4EALDH1A1HPGD | |
| SCHEMBL4297280 | 0.89 | ADRB2 (0.54) | ADRB2KCNH2GSK3BKDM4EALDH1A1 | |
| SCHEMBL7011806 | 0.89 | ADRB2 (0.59) | ADRB2KCNH2KDM4EALDH1A1HPGD | |
| SCHEMBL30891261 | 0.88 | ADRB2 (0.56) | ADRB2KCNH2GSK3BKDM4EALDH1A1 | |
| SCHEMBL30944906 | 0.88 | ADRB2 (0.56) | ADRB2KCNH2GSK3BKDM4EALDH1A1 | |
| SCHEMBL5704361 | 0.88 | ADRB2 (0.56) | ADRB2KCNH2GSK3BKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4644391-A1 | NOVEL PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTICANCER FUNCTIONS, AND PREPARATION THEREOF | Alphamol Science Ltd (Shanghai) (CN) | 2025-11-05 | — | — | EP | disclosed |
| EP-4644376-A1 | NEW PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTI-CANCER FUNCTIONS AND PREPARATION THEREOF | Alphamol Science Ltd (Shanghai) (CN) | 2025-11-05 | — | — | EP | disclosed |
| WO-2024138292-A1 | NOVEL PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTICANCER FUNCTIONS, AND PREPARATION THEREOF | 深圳阿尔法分子科技有限责任公司 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024138292-A1 | NOVEL PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTICANCER FUNCTIONS, AND PREPARATION THEREOF | 深圳阿尔法分子科技有限责任公司 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024141126-A1 | NEW PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTI-CANCER FUNCTIONS AND PREPARATION THEREOF | 深圳阿尔法分子科技有限责任公司 | 2024-07-04 | — | — | WO | disclosed |
| EP-0775702-B1 | NOVEL QUINOLONE- OR NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO LTD (JP) | 2003-07-23 | — | — | EP | disclosed |
| US-20020049223-A1 | Quinoline and naphthyridine carboxylic acid antibacterials | ABBOTT LABORATORIES | 2002-04-25 | — | — | US | disclosed |
| US-5935952-A | ANTIBACTERIAL AGENT | TOYAMA CHEMICAL CO., LTD. (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0775702-A1 | NOVEL QUINOLONE- OR NAPHTHYRIDONECARBOXYLIC ACID DERIVATIVE OR SALT THEREOF | TOYAMA CHEMICAL CO., LTD. (JP) | 1997-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049223-A1 | Quinoline and naphthyridine carboxylic acid antibacterials | NQO2, NQO1, NDUFA7 | ADRB2 3198/4885KCNH2 2211/4885GSK3B 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.